Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

860
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
860
Hazard Ratio01:12

Hazard Ratio

551
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
551
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

136
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
136
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

541
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
541

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal of the National Cancer Institute·2026
Same author

WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.

NPJ breast cancer·2026
Same author

Autostaining Immune Multiplex Immunohistochemistry Panels and Imaging Analysis.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

Science translational medicine·2026
Same author

Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.

Communications medicine·2026
Same author

Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity.

The Journal of clinical investigation·2026
Same journal

Somatosensory cortex shapes perceptual decision bias via the superior colliculus.

Research square·2026
Same journal

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Research square·2026
Same journal

Supporting Implementation of the National Standards for Cancer Survivorship Care: Development of the Cancer Survivorship Maturity Model (CSMM).

Research square·2026
Same journal

Operationalizing a walking exercise prescription based on 6-minute walk test results.

Research square·2026
Same journal

Age but not sex modifies lymphoid immune responses in murine sepsis.

Research square·2026
Same journal

Indirect effect, through aspects of neighborhood affluence and racial/ethnic composition, of receiving a Section 8 voucher on the prevalence of psychiatric disorders among boys and girls in the Moving to Opportunity study.

Research square·2026
查看所有相关文章

相关实验视频

Updated: Jan 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

智慧随机试验比较基于风险的与年度乳腺癌查:研究队列特征和设计.

Allison Fiscalini1, Kelly Blum1, Kirkpatrick Fergus1

  • 1University of California, San Francisco, San Francisco, CA, USA.

Research square
|November 19, 2025
PubMed
概括
此摘要是机器生成的。

根据风险衡量标准进行查的妇女 (WISDOM) 研究发现,大多数女性更喜欢基于风险的乳腺癌查. 这项实用性试验评估了个性化查计划,显示了患者对量身定制方法的强烈偏好.

关键词:
乳腺癌 乳腺癌 乳腺癌多基因风险评分 (Polygenic Risk Score) 是一种多基因风险评分.预防 预防 预防随机对照试验 随机对照试验查检查 查检查 查检查

更多相关视频

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

785
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

相关实验视频

Last Updated: Jan 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

785
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

科学领域:

  • 在瘤学瘤学.
  • 预防医学 预防医学
  • 临床试验 临床试验

背景情况:

  • 乳腺癌查指南缺乏个性化.
  • 风险评估模型可以为定制的查策略提供信息.
  • 根据风险衡量标准进行查的妇女 (WISDOM) 研究解决了这一差距.

研究的目的:

  • 评估一种基于风险的方法来确定乳腺癌查的开始年龄,频率和方式.
  • 在实用试验框架内评估参与者对不同查策略的偏好.
  • 将基于风险的查与标准的查协议进行比较.

主要方法:

  • 一个实用的随机对照试验 (NCT02620852) 具有偏好耐受的设计.
  • 包括使用乳腺癌监测联盟 (BCSC) 模型和遗传因素进行全面的乳腺癌风险评估.
  • 从2016年8月到2023年2月,招募了46,403名参与者的多元化,全国性的队列.

主要成果:

  • 61%的参与者 (28,372) 被随机选择;89%的自我选择手臂的人选择了基于风险的查.
  • 该研究招募了大量,多样化的队列,随着时间的推移,人口代表性不断增加.
  • 观察到参与者对基于风险的乳腺癌查的强烈偏好.

结论:

  • 一个偏好耐受的设计有效地捕捉了现实世界的查偏好,同时保持科学严谨性.
  • 基于风险的乳腺癌查被大多数女性强烈偏爱.
  • 个性化查策略具有显著的潜力,可以改善遵守和结果.